AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment
05/10/2026 17:14
AstraZeneca opens new Massachusetts R&D center as part of $1 billion investment Oct 5 (Reuters) - AstraZeneca AZN.L said on Monday it had opened a new research and development center in Cambridge, Massachusetts, as part of a more than $1 billion investment in the state to expand its research operations and workforce.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Maju Samuel)
Recent news on AstraZeneca
See all newsAstraZeneca says FDA approves drug for rare kidney disease in adults
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Early US flu season, current strain may signal risk for younger people; doctors urge shots
AstraZeneca partners with Oracle for AI-driven clinical trials
Factbox: Pharma sector doubles down on AI to slash costs, timelines